Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2025-09-03 00:00:00 ET · period of report 2025-08-29 · accession 0000874015-25-000190 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-03 | 2025-08-29 | IONS | Geary Richard S | EVP, Chief Development Off | J - Other | $27.71 | +165 | 89.7K | +0.2% | +$4,572 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-29 | J | A | 165 | $27.71 | 89,657 | D | — | — | (F1) Reporting shares purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 29, 2025. These shares may not be sold until March 2, 2026. |